Neurophet, a Korean medical AI company, said on Monday that it signed an exclusive agreement with Clairvo Technologies to sell Neurophet Aqua, its flagship degenerative neurological disease diagnosis assistant software, in Japan.
Earlier in March, Neurophet obtained medical device certification for Neurophet Aqua from Japan's Ministry of Health, Labor and Welfare (MHLW). Accordingly, Neurophet will now conduct sales, marketing, and promotional activities with Clairvo to sell Neurophet Aqua in Japan, the Korean company said.
Neurophet Aqua quantitatively analyses brain MRI with AI technology to detect brain atrophy and degeneration of white matter observed in neurodegenerative diseases such as Alzheimer's disease and vascular dementia.
The patient's brain image is divided into 35 major regions and brain volume atrophy, brain aging, and white matter degeneration analysis are compared to normal people of the same age and gender and compiled in a report.
With high analysis accuracy, Neurophet Aqua significantly reduced the software analysis time from 8 to 24 hours on competing technologies to just 5 minutes, according to the company.
Brain image analysis is possible regardless of all races, ages, and genders, and consistent results are derived from images of various MRI devices such as GE, Philips, and Canon.
Clairvo is owned by the Marubeni Group, one of Japan's top five general companies. It imports medical devices from the United States and Taiwan and distributes them in the Japanese market.
"Korea's medical AI technology is recognized not only in Japan but around the world as it stands out at international conferences," said Clairvo CEO Riichi Yamada. "We expect Neurophet Aqua to be in high demand in the Japanese medical market."
Neurophet CEO Been Jun-kil said the company secured a business partner that can directly sell and distribute in Asia's largest medical device market, through this contract with Clairvo.
"We plan to accelerate efforts to target global markets so we can expand product sales in overseas markets such as the U.S., Europe, and Southeast Asia in the future," he said.